New Mountain Finance (NMFC) Q2 2026 earnings review
The Bleeding Stops: NAV Stabilizes as New Baseline Takes Hold
After four consecutive quarters of severe book value destruction and a painful 22% dividend cut, New Mountain Finance Corporation (NMFC) has finally stabilized the ship. Net Asset Value (NAV) flattened out at $10.89 (down just $0.03 sequentially), halting a violent slide that erased over $1.30 per share since early 2025. Adjusted Net Investment Income (NII) reset exactly as management telegraphed, coming in at $0.26 and narrowly covering the new $0.25 dividend. Most critically, non-accruals reversed sharply from a concerning 2.6% down to 1.5%. The aggressive Q1 portfolio restructuring traded historical earnings power for balance sheet stability, and for now, that tradeoff is working.
🐂 Bull Case
The alarming spike in non-accruals to 2.6% in Q1 was reversed, falling aggressively back to 1.5%. Approximately 88% of the portfolio is rated 'green' on their internal heatmap, suggesting the core book remains highly resilient.
Insider ownership has climbed to an impressive 18%. Management isn't just defending the stock verbally; they are buying heavily alongside ongoing corporate share repurchases, putting a hard floor under the stock's valuation.
🐻 Bear Case
The days of earning $0.32 per share are gone. NII has decelerated sharply to $0.26. The Q1 portfolio sale purged high-yielding (but riskier) assets, permanently reducing the baseline income generated by this portfolio.
Despite management's Q1 narrative about 'de-risking and deleveraging', statutory debt-to-equity actually ticked up sequentially from 1.12x to 1.16x, leaving less dry powder for new deployments.
⚖️ Verdict: ⚪
Neutral. Management successfully executed a difficult turnaround. The NAV free-fall is over, and the new $0.25 dividend is covered by core NII. However, with the portfolio actively shrinking and leverage ticking back up, the upside catalysts are limited until legacy equity assets are monetized.
Key Themes
Credit Quality: Sudden Non-Accrual Reversal
The biggest positive surprise in Q2 was the sharp reversal in non-accruals. After jumping to 2.6% of fair value in Q1 (driven by Affordable Care and Convey), non-accruals decelerated heavily back down to 1.5%. This indicates successful, rapid intervention by New Mountain's workout teams. Removing these drags on yield is critical to maintaining the new $0.26 NII baseline.
Contradictory Deleveraging Narrative
In Q1, management heavily promoted their $470M asset sale as a way to de-lever the balance sheet. Yet, in Q2, statutory debt-to-equity increased to 1.16x from 1.12x. Furthermore, the portfolio shrank by $23.6M (originations of $73.3M failed to outpace $104.4M in combined sales and repayments). Borrowing more money while the income-producing asset base shrinks is a negative divergence that warrants heavy scrutiny.
The 'Systems of Record' Software Bet
Software remains NMFC's second-largest sector at 19.8% of the portfolio (down slightly from 22.2% at year-end 2025). While macro headwinds and the 'SaaS-pocalypse' dominate broader tech lending fears, management consistently defends this allocation. They focus on 'systems of record' (ERP, HR, Finance) with loan-to-values historically capped under 40%. The stable NAV this quarter suggests this defensive software underwriting is holding up against multiple compression.
The Ghost of Legacy Equity
A key piece of the bull thesis from the Q1 strategic pivot was the planned monetization of non-yielding legacy equity positions (specifically Benevis, Edmentum, and UniTek). There was no mention of successful equity exits in the Q2 release. Until these non-earning assets are converted into cash-yielding debt, the company's ability to drive NII growth above the $0.26 baseline remains structurally capped.
Shareholder Alignment: Insider Buying & Buybacks
Management continues to use the stock's massive discount to book value (trading at an implied ~15% yield) to their advantage. Insider ownership has reached 18% (up from 14% late last year). This alignment is a massive structural driver; every share repurchased at ~$8 against a $10.89 NAV creates immediate, permanent accretion for remaining shareholders.
Other KPIs
Decelerating. The portfolio size contracted slightly from $2,319.1 million in 26Q1 and is down heavily from the $2,755.5 million peak in 25Q4 prior to the Coller Capital secondary sale. Negative net deployment (originations less repayments/sales) is currently starving the top line of new interest income.
Stable. When combined with Senior Loan Funds (16.8%), the portfolio's senior-oriented mix sits near 80%. This confirms management's promise to maintain a highly defensive, top-of-the-capital-structure orientation following the Q1 purge of subordinated and PIK-heavy assets.
Guidance
Stable sequentially, but represents a 21.8% deceleration compared to the $0.32 dividend paid in Q3 2025. This formally establishes $0.25 as the new, sustainable baseline going forward. At current NII levels ($0.26), the dividend coverage ratio is a tight but functional 104%.
Key Questions
Non-Accrual Mechanics
Non-accruals dropped impressively from 2.6% to 1.5%. How much of this reduction was achieved through successful operational restructuring (returning assets like Affordable Care or Convey to accrual status) versus realizing permanent write-offs?
Leverage Tick-Up
Statutory debt-to-equity increased to 1.16x despite net portfolio shrinkage of roughly $24 million. What drove the increased utilization of leverage during a quarter of negative net deployment?
Legacy Equity Monetization Timeline
In Q1, the monetization of non-yielding equity in names like Benevis and UniTek was cited as the 'next step' in transforming the company. What is the realistic timeline for these exits in the current M&A environment?